CFDE Data Portal | Search FMO4

	Label	Description
	FMO4 Gene (Entity type)	ENSG00000076258 - flavin containing dimethylaniline monoxygenase 4
	FMO4 associations Collection (Entity type)	Associations for FMO4_associations
	FMO4 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	FMO4 HUMAN Protein (Entity type)	Dimethylaniline monooxygenase [N-oxide-forming] 4
	FMO4 MOUSE Protein (Entity type)	Dimethylaniline monooxygenase [N-oxide-forming] 4
	FMO4 RAT Protein (Entity type)	Dimethylaniline monooxygenase [N-oxide-forming] 4
	GSE135514 8 V 7 DASATINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE225869 1 V 0 TEMOZOLOMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE131887 5 V 2 DOXYCYCLINE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE205729,GSE205731 2 V 3 TAZEMETOSTAT HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

FMO4

ENSG00000076258 - flavin containing dimethylaniline monoxygenase 4

FMO4 associations

Associations for FMO4_associations

FMO4 associations.tsv

A file from IDG as part of the Harmonizome project

FMO4 HUMAN

Dimethylaniline monooxygenase [N-oxide-forming] 4

FMO4 MOUSE

Dimethylaniline monooxygenase [N-oxide-forming] 4

FMO4 RAT

Dimethylaniline monooxygenase [N-oxide-forming] 4

GSE135514 8 V 7 DASATINIB HUMAN DN

A Gene Set from LINCS

GSE225869 1 V 0 TEMOZOLOMIDE HUMAN DN

A Gene Set from LINCS

GSE131887 5 V 2 DOXYCYCLINE MOUSE UP

A Gene Set from LINCS

GSE205729,GSE205731 2 V 3 TAZEMETOSTAT HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.